Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FOXO3 gene therapy
- Development stage
- Preclinical
- Lead developer
- VitaDAO
- Modality
- Gene Therapies
- Administration
- Intratracheal, Intraarticular, Intracranial
01
Overview
**FOXO3 gene therapy** is an early-stage longevity program being advanced by VitaDAO that aims to modulate expression and activity of **forkhead box O3** to promote stress resilience and healthy aging biology. Based on VitaDAO project materials, the program is described as a **single-dose AAV gene therapy** focused on FOXO3 longevity biology, with the therapeutic concept centered on increasing or tuning FOXO3-driven pro-longevity pathways relevant to aging and longevity. The asset appears to be a preclinical or discovery-stage gerotherapeutic program rather than a marketed product, and no specific commercial brand name, administration route, or final clinical formulation has been publicly established.
- Other names
- Vita FOXO3 gene therapy
02
Targets
FOXO3 (Forkhead box protein O3)
Beyond the preview
Go deeper on FOXO3 gene therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FOXO3 gene therapy.